VIVI — TempraMed Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- CA$93.20m
- CA$99.36m
- $2.26m
Annual cashflow statement for TempraMed Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -1.24 | -3.25 | -3.35 |
| Depreciation | |||
| Non-Cash Items | 0.014 | 1.87 | 2.16 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.325 | 0.842 | 0.21 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Payable / Accrued Expenses | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -0.873 | -0.494 | -0.941 |
| Capital Expenditures | -0.107 | -0.003 | 0 |
| Purchase of Fixed Assets | |||
| Cash from Investing Activities | -0.107 | -0.003 | 0 |
| Financing Cash Flow Items | 0.75 | 0 | 0 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0.893 | 0.54 | 0.909 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -0.087 | 0.043 | -0.032 |